At McKesson Medical-Surgical, we are aware of the U.S. Food and Drug Administration’s (FDA) communications and actions regarding quality and performance issues with plastic syringes made in China.
As a result, we have stopped shipping the products specified in FDA’s Warning Letters issued on March 18, 2024 and July 18, 2024. McKesson Medical-Surgical is continuing to engage with Cardinal Health regarding the Warning Letter it received on April 24, 2024 to determine if any additional action is required.
We continue to work with our suppliers to help ensure that all necessary actions are taken in response to Warning Letters, Import Alerts and recalls. This applies to both our privately labeled McKesson Brands and national brand products.
Our team remains committed to patient safety and quality assurance. We also understand the importance of having a resilient supply chain, which is why we source products from a variety of suppliers and countries and continuously look to expand our supplier network. We encourage customers to contact their Account Executive or our Customer Service team at MMSSyringe@McKesson.com so that we can help identify an alternate product to meet your needs.
We encourage you to read the information and resources available on this site and continue to monitor for updates.